Page last updated: 2024-10-29

ifosfamide and Obesity

ifosfamide has been researched along with Obesity in 2 studies

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"In summary, female sex, low total bilirubin, albumin and haemoglobin levels, and obesity appear to be associated with ifosfamide-induced encephalopathy."4.84Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature. ( Beri, R; Shord, SS; Sweiss, KI, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sweiss, KI1
Beri, R1
Shord, SS1
Lind, MJ1
Margison, JM1
Cerny, T1
Thatcher, N1
Wilkinson, PM1

Reviews

1 review available for ifosfamide and Obesity

ArticleYear
Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
    Drug safety, 2008, Volume: 31, Issue:11

    Topics: Adult; Albumins; Antineoplastic Agents, Alkylating; Bilirubin; Brain Diseases; Cohort Studies; Enzym

2008

Other Studies

1 other study available for ifosfamide and Obesity

ArticleYear
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chromat

1989